Emergent

Company Overview

Emergent Bioservices is the CDMO division of Emergent Biosolutions, a life sciences company that provides preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). Emergent specializes in engaging and fighting the most severe intentional and natural threats to public health, including anthrax, ebola, smallpox, botulism and opioid addiction.

The company operates in two segments. Its Products Segment consists of Government—MCM and Commercial products. It Services Segment consists of its CDMO services portfolio. The CDMO services includes development services (process and analytical development); drug substance manufacturing; and drug product manufacturing (fill/finish).

These services, which are collectively referred to as a molecule-to-market offering, employ diverse technology platforms across a network of development and manufacturing sites. These CDMO services support all drug development life cycle phases, from pre-clinical development programs to commercial manufacturing of approved pharmaceutical products.

Financial Highlights (FY 2023)

Company's Business Segments

• Commercial Product sales : NARCAN, Other commercial products
• MCM product sales : Anthrax MCM products, Smallpox MCM products, Other Products
• Services : Bioservices portfolio